EP Patent

EP3308771A1 — Compositions and methods for enhancing the efficacy of contraceptive microbicides

Assigned to Evofem Inc · Expires 2018-04-18 · 8y expired

What this patent protects

The present disclosure relates to compositions and methods for contraception that also enhance the efficacy of microbicides. Such compositions serve the dual purpose of preventing pregnancy and lessening the risk of spreading sexually transmitted diseases. More specifically, the …

USPTO Abstract

The present disclosure relates to compositions and methods for contraception that also enhance the efficacy of microbicides. Such compositions serve the dual purpose of preventing pregnancy and lessening the risk of spreading sexually transmitted diseases. More specifically, the compositions and methods relate to contraceptive microbicides optionally in combination with an antiviral agent, said compositions comprising a matrix forming compound and an acidic carrier that enhance the efficacy of the contraceptive microbicide and optionally the antiviral agent.

Drugs covered by this patent

Patent Metadata

Patent number
EP3308771A1
Jurisdiction
EP
Classification
—
Expires
2018-04-18
Drug substance claim
No
Drug product claim
No
Assignee
Evofem Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.